Discover all the latest news and resources about plasma donation and plasma-derived products.
How media portrayals of plasma donation are shifting
03/06/2025
Tom Hanks' plasma donation during COVID-19 brought positive attention to plasma donation, which is often negatively portrayed in society as desperate people "selling blood."
Plasma treatments like therapeutic plasma exchange join traditional cancer therapies to fight disease and ease symptoms, giving more patients hope for recovery.
Those with alpha-1 antitrypsin deficiency depend on plasma donations
07/16/2024
Many rare, chronic conditions with no known cures, including alpha-1 antitrypsin deficiency, can be managed with augmentation therapy treatments made from donated plasma.
Plasma is a vital weapon against tetanus and rabies
05/20/2024
While tetanus and rabies are fairly rare in the United States today, these deadly diseases still pose a major global health threat. However, plasma-derived antibody products play a crucial role in treating these illnesses around the world.
Congressional Plasma Caucus formed to address concerns of constituents
04/25/2024
Members of the congressional Plasma Caucus provide a venue to educate legislators on important legislation to provide access to patients who rely on immunoglobulin (Ig) therapy.
Plasma demand is on the rise because of new patients and products
03/26/2024
The need for plasma is forecasted to increase since more patients are being diagnosed with current and newly discovered rare conditions as well as additional indications being approved for plasma medications.
Science is driving global advancements in policy and allowing more people around the world to donate plasma while ensuring the safety of donors and the plasma collected.
Plasma has been used to treat bleeding disorders like hemophilia since the 1950s, and is still one of the most effective treatment options for patients.
Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyneuropathy (CIDP) are rare neurological disorders and plasma-based therapies are used to treat them.
FDA proposes risk-based rules for plasma and blood donations
05/17/2023
On January 27, 2023, the U.S. Food and Drug Administration announced a draft proposal for eligibility rules for blood and blood product donation using “gender-inclusive, individual risk-based questions to reduce the risk of transfusion-transmitted HIV.”
SPS is a rare and progressive neurological disease. It affects one person in a million and Celine Dion is one of those people relying on plasma donation to treat the condition.
Plasma Hero joins national patient organizations created to address the unique needs of patients with rare diseases who use lifesaving plasma protein therapies.
